Skip to main content
. 2022 Oct 25;305(3):512–525. doi: 10.1148/radiol.220585

Figure 5:

Images in an 81-year-old man who presented with cough and back pain. The patient was a former smoker. (A, B) Fluorodeoxyglucose (FDG) PET/CT scans demonstrate a left hilar mass (arrow in A) with mediastinal and left hilar lymphadenopathy (arrow in B) and bone metastasis, representing extensive stage small cell lung cancer. (C, D) Bone metastasis in the left iliac bone is better seen on PET/CT scan (C) as intense focal FDG uptake (circle in C) without definitive correlate on CT scan (D) (circle in D). (E) Chest CT scan at diagnosis also demonstrates severe centrilobular emphysema with mild peribronchial thickening in the underlying lungs in this former smoker. The patient received several lines of systemic therapy, including carboplatin and etoposide, irinotecan, and nivolumab; however, disease progressed and the patient died 10 months after the diagnosis.

Images in an 81-year-old man who presented with cough and back pain. The patient was a former smoker. (A, B) Fluorodeoxyglucose (FDG) PET/CT scans demonstrate a left hilar mass (arrow in A) with mediastinal and left hilar lymphadenopathy (arrow in B) and bone metastasis, representing extensive stage small cell lung cancer. (C, D) Bone metastasis in the left iliac bone is better seen on PET/CT scan (C) as intense focal FDG uptake (circle in C) without definitive correlate on CT scan (D) (circle in D). (E) Chest CT scan at diagnosis also demonstrates severe centrilobular emphysema with mild peribronchial thickening in the underlying lungs in this former smoker. The patient received several lines of systemic therapy, including carboplatin and etoposide, irinotecan, and nivolumab; however, disease progressed and the patient died 10 months after the diagnosis.